Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 194 entries
Sorted by: Best Match Show Resources per page
A way forward to the elimination of conflict of interest for experts involved in regulatory medicine and guidelines.

European heart journal. Cardiovascular pharmacotherapy

Rosano GM, Ceconi C.
PMID: 27533973
Eur Heart J Cardiovasc Pharmacother. 2015 Apr;1(2):80-1. doi: 10.1093/ehjcvp/pvu005.

No abstract available.

Cite
Rosano GM, Ceconi C. A way forward to the elimination of conflict of interest for experts involved in regulatory medicine and guidelines. Eur Heart J Cardiovasc Pharmacother. 2015;1(2):80-1doi: 10.1093/ehjcvp/pvu005.
Rosano, G. M., & Ceconi, C. (2015). A way forward to the elimination of conflict of interest for experts involved in regulatory medicine and guidelines. European heart journal. Cardiovascular pharmacotherapy, 1(2), 80-1. https://doi.org/10.1093/ehjcvp/pvu005
Rosano, Giuseppe M C, and Ceconi, Claudio. "A way forward to the elimination of conflict of interest for experts involved in regulatory medicine and guidelines." European heart journal. Cardiovascular pharmacotherapy vol. 1,2 (2015): 80-1. doi: https://doi.org/10.1093/ehjcvp/pvu005
Rosano GM, Ceconi C. A way forward to the elimination of conflict of interest for experts involved in regulatory medicine and guidelines. Eur Heart J Cardiovasc Pharmacother. 2015 Apr;1(2):80-1. doi: 10.1093/ehjcvp/pvu005. PMID: 27533973.
Copy Download .nbib Format: NLM
HFA Congress 2017: The Congress of the Heart Failure Association of the ESC: a continuous success story, the result of a long-term vision.

European heart journal

Rosano GMC.
PMID: 29099987
Eur Heart J. 2017 Nov 01;38(41):3042-3043. doi: 10.1093/eurheartj/ehx522.

No abstract available.

Cite
Rosano GMC. HFA Congress 2017: The Congress of the Heart Failure Association of the ESC: a continuous success story, the result of a long-term vision. Eur Heart J. 2017;38(41):3042-3043doi: 10.1093/eurheartj/ehx522.
Rosano, G. M. C. (2017). HFA Congress 2017: The Congress of the Heart Failure Association of the ESC: a continuous success story, the result of a long-term vision. European heart journal, 38(41), 3042-3043. https://doi.org/10.1093/eurheartj/ehx522
Rosano, Giuseppe M C. "HFA Congress 2017: The Congress of the Heart Failure Association of the ESC: a continuous success story, the result of a long-term vision." European heart journal vol. 38,41 (2017): 3042-3043. doi: https://doi.org/10.1093/eurheartj/ehx522
Rosano GMC. HFA Congress 2017: The Congress of the Heart Failure Association of the ESC: a continuous success story, the result of a long-term vision. Eur Heart J. 2017 Nov 01;38(41):3042-3043. doi: 10.1093/eurheartj/ehx522. PMID: 29099987.
Copy Download .nbib Format: NLM
Improvement of skeletal muscle performance in ageing by the metabolic modulator Trimetazidine.

Journal of cachexia, sarcopenia and muscle

Ferraro E, Pin F, Gorini S, Pontecorvo L, Ferri A, Mollace V, Costelli P, Rosano G.
PMID: 27239426
J Cachexia Sarcopenia Muscle. 2016 Sep;7(4):449-57. doi: 10.1002/jcsm.12097. Epub 2016 Jan 05.

BACKGROUND: The loss of muscle mass (sarcopenia) and the associated reduced muscle strength are key limiting factors for elderly people's quality of life. Improving muscle performance does not necessarily correlate with increasing muscle mass. In fact, particularly in the...

Cite
Ferraro E, Pin F, Gorini S, et al. Improvement of skeletal muscle performance in ageing by the metabolic modulator Trimetazidine. J Cachexia Sarcopenia Muscle. 2016;7(4):449-57doi: 10.1002/jcsm.12097.
Ferraro, E., Pin, F., Gorini, S., Pontecorvo, L., Ferri, A., Mollace, V., Costelli, P., & Rosano, G. (2016). Improvement of skeletal muscle performance in ageing by the metabolic modulator Trimetazidine. Journal of cachexia, sarcopenia and muscle, 7(4), 449-57. https://doi.org/10.1002/jcsm.12097
Ferraro, Elisabetta, et al. "Improvement of skeletal muscle performance in ageing by the metabolic modulator Trimetazidine." Journal of cachexia, sarcopenia and muscle vol. 7,4 (2016): 449-57. doi: https://doi.org/10.1002/jcsm.12097
Ferraro E, Pin F, Gorini S, Pontecorvo L, Ferri A, Mollace V, Costelli P, Rosano G. Improvement of skeletal muscle performance in ageing by the metabolic modulator Trimetazidine. J Cachexia Sarcopenia Muscle. 2016 Sep;7(4):449-57. doi: 10.1002/jcsm.12097. Epub 2016 Jan 05. PMID: 27239426; PMCID: PMC4864287.
Copy Download .nbib Format: NLM
Effect of glucocorticoids on development of the membrane resting potential of chick embryo brain cells in culture.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience

Romano MC, Velázquez PN, Nún̄ez MB, Fuentes-Pardo B.
PMID: 24874961
Int J Dev Neurosci. 1985;3(5):521-9. doi: 10.1016/0736-5748(85)90041-3.

Progressive increase in membrane resting potential (MRP) values in cultured chick embryo brain neurons were recorded from days 2 to 10 of development. Application of corticosterone or prednisone in 24 hr old cultured cells caused a significant increment in...

Cite
Romano MC, Velázquez PN, Nún̄ez MB, et al. Effect of glucocorticoids on development of the membrane resting potential of chick embryo brain cells in culture. Int J Dev Neurosci. 1985;3(5):521-9doi: 10.1016/0736-5748(85)90041-3.
Romano, M. C., Velázquez, P. N., Nún̄ez, M. B., & Fuentes-Pardo, B. (1985). Effect of glucocorticoids on development of the membrane resting potential of chick embryo brain cells in culture. International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience, 3(5), 521-9. https://doi.org/10.1016/0736-5748(85)90041-3
Romano, M C, et al. "Effect of glucocorticoids on development of the membrane resting potential of chick embryo brain cells in culture." International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience vol. 3,5 (1985): 521-9. doi: https://doi.org/10.1016/0736-5748(85)90041-3
Romano MC, Velázquez PN, Nún̄ez MB, Fuentes-Pardo B. Effect of glucocorticoids on development of the membrane resting potential of chick embryo brain cells in culture. Int J Dev Neurosci. 1985;3(5):521-9. doi: 10.1016/0736-5748(85)90041-3. PMID: 24874961.
Copy Download .nbib Format: NLM
The use of sugammadex for bariatric surgery: analysis of recovery time from neuromuscular blockade and possible economic impact.

ClinicoEconomics and outcomes research : CEOR

De Robertis E, Zito Marinosci G, Romano GM, Piazza O, Iannuzzi M, Cirillo F, De Simone S, Servillo G.
PMID: 27418846
Clinicoecon Outcomes Res. 2016 Jun 29;8:317-22. doi: 10.2147/CEOR.S109951. eCollection 2016.

BACKGROUND: Neuromuscular block (NMB) monitoring and use of reversal agents accelerate the recovery time and improve the workflow in the operating room. We aimed to compare recovery times after sugammadex or neostigmine administration, and estimate the time spent in...

Cite
De Robertis E, Zito Marinosci G, Romano GM, et al. The use of sugammadex for bariatric surgery: analysis of recovery time from neuromuscular blockade and possible economic impact. Clinicoecon Outcomes Res. 2016;8:317-22doi: 10.2147/CEOR.S109951.
De Robertis, E., Zito Marinosci, G., Romano, G. M., Piazza, O., Iannuzzi, M., Cirillo, F., De Simone, S., & Servillo, G. (2016). The use of sugammadex for bariatric surgery: analysis of recovery time from neuromuscular blockade and possible economic impact. ClinicoEconomics and outcomes research : CEOR, 8317-22. https://doi.org/10.2147/CEOR.S109951
De Robertis, Edoardo, et al. "The use of sugammadex for bariatric surgery: analysis of recovery time from neuromuscular blockade and possible economic impact." ClinicoEconomics and outcomes research : CEOR vol. 8 (2016): 317-22. doi: https://doi.org/10.2147/CEOR.S109951
De Robertis E, Zito Marinosci G, Romano GM, Piazza O, Iannuzzi M, Cirillo F, De Simone S, Servillo G. The use of sugammadex for bariatric surgery: analysis of recovery time from neuromuscular blockade and possible economic impact. Clinicoecon Outcomes Res. 2016 Jun 29;8:317-22. doi: 10.2147/CEOR.S109951. eCollection 2016. PMID: 27418846; PMCID: PMC4934482.
Copy Download .nbib Format: NLM
The reply.

The American journal of medicine

Pelliccia F, Rosano G.
PMID: 25812636
Am J Med. 2015 Apr;128(4):e11. doi: 10.1016/j.amjmed.2014.11.014.

No abstract available.

Cite
Pelliccia F, Rosano G. The reply. Am J Med. 2015;128(4):e11doi: 10.1016/j.amjmed.2014.11.014.
Pelliccia, F., & Rosano, G. (2015). The reply. The American journal of medicine, 128(4), e11. https://doi.org/10.1016/j.amjmed.2014.11.014
Pelliccia, Francesco, and Rosano, Giuseppe. "The reply." The American journal of medicine vol. 128,4 (2015): e11. doi: https://doi.org/10.1016/j.amjmed.2014.11.014
Pelliccia F, Rosano G. The reply. Am J Med. 2015 Apr;128(4):e11. doi: 10.1016/j.amjmed.2014.11.014. PMID: 25812636.
Copy Download .nbib Format: NLM
The metabolic syndrome in women.

Women's health (London, England)

Rosano GM, Vitale C, Mercuro G.
PMID: 19804009
Womens Health (Lond). 2006 Nov;2(6):889-98. doi: 10.2217/17455057.2.6.889.

The clustering of metabolic risk factors, overweight and hypertension is of particular importance in postmenopausal women due to the negative effect of menopause on bodyweight, glucose metabolism and the development of hypertension. Menopause acts directly as a risk factor...

Cite
Rosano GM, Vitale C, Mercuro G. The metabolic syndrome in women. Womens Health (Lond). 2006;2(6):889-98doi: 10.2217/17455057.2.6.889.
Rosano, G. M., Vitale, C., & Mercuro, G. (2006). The metabolic syndrome in women. Women's health (London, England), 2(6), 889-98. https://doi.org/10.2217/17455057.2.6.889
Rosano, Giuseppe Mc, et al. "The metabolic syndrome in women." Women's health (London, England) vol. 2,6 (2006): 889-98. doi: https://doi.org/10.2217/17455057.2.6.889
Rosano GM, Vitale C, Mercuro G. The metabolic syndrome in women. Womens Health (Lond). 2006 Nov;2(6):889-98. doi: 10.2217/17455057.2.6.889. PMID: 19804009.
Copy Download .nbib Format: NLM
Vitamin D: a novel player in endothelial function and dysfunction.

Archives of medical science : AMS

Caprio M, Mammi C, Rosano GM.
PMID: 22457665
Arch Med Sci. 2012 Feb 29;8(1):4-5. doi: 10.5114/aoms.2012.27271.

No abstract available.

Cite
Caprio M, Mammi C, Rosano GM. Vitamin D: a novel player in endothelial function and dysfunction. Arch Med Sci. 2012;8(1):4-5doi: 10.5114/aoms.2012.27271.
Caprio, M., Mammi, C., & Rosano, G. M. (2012). Vitamin D: a novel player in endothelial function and dysfunction. Archives of medical science : AMS, 8(1), 4-5. https://doi.org/10.5114/aoms.2012.27271
Caprio, Massimiliano, et al. "Vitamin D: a novel player in endothelial function and dysfunction." Archives of medical science : AMS vol. 8,1 (2012): 4-5. doi: https://doi.org/10.5114/aoms.2012.27271
Caprio M, Mammi C, Rosano GM. Vitamin D: a novel player in endothelial function and dysfunction. Arch Med Sci. 2012 Feb 29;8(1):4-5. doi: 10.5114/aoms.2012.27271. PMID: 22457665; PMCID: PMC3309427.
Copy Download .nbib Format: NLM
Complete Mesocolic Excision With Central Vascular Ligation in Comparison With Conventional Surgery for Patients With Colon Cancer - The Experiences at Two Centers.

Annals of coloproctology

Abdelkhalek M, Setit A, Bianco F, Belli A, Denewer A, Youssef TF, Falato A, Romano GM.
PMID: 30208681
Ann Coloproctol. 2018 Aug;34(4):180-186. doi: 10.3393/ac.2017.08.05. Epub 2018 Aug 31.

PURPOSE: Revolutions have occurred over the last 3 decades in the management of patients with colorectal cancer. Most advances were in rectal cancer surgery, especially after the introduction of the total mesorectal excision (TME) by Heald. However, no parallel...

Cite
Abdelkhalek M, Setit A, Bianco F, et al. Complete Mesocolic Excision With Central Vascular Ligation in Comparison With Conventional Surgery for Patients With Colon Cancer - The Experiences at Two Centers. Ann Coloproctol. 2018;34(4):180-186doi: 10.3393/ac.2017.08.05.
Abdelkhalek, M., Setit, A., Bianco, F., Belli, A., Denewer, A., Youssef, T. F., Falato, A., & Romano, G. M. (2018). Complete Mesocolic Excision With Central Vascular Ligation in Comparison With Conventional Surgery for Patients With Colon Cancer - The Experiences at Two Centers. Annals of coloproctology, 34(4), 180-186. https://doi.org/10.3393/ac.2017.08.05
Abdelkhalek, Mohamed, et al. "Complete Mesocolic Excision With Central Vascular Ligation in Comparison With Conventional Surgery for Patients With Colon Cancer - The Experiences at Two Centers." Annals of coloproctology vol. 34,4 (2018): 180-186. doi: https://doi.org/10.3393/ac.2017.08.05
Abdelkhalek M, Setit A, Bianco F, Belli A, Denewer A, Youssef TF, Falato A, Romano GM. Complete Mesocolic Excision With Central Vascular Ligation in Comparison With Conventional Surgery for Patients With Colon Cancer - The Experiences at Two Centers. Ann Coloproctol. 2018 Aug;34(4):180-186. doi: 10.3393/ac.2017.08.05. Epub 2018 Aug 31. PMID: 30208681; PMCID: PMC6140369.
Copy Download .nbib Format: NLM
Frailty in Heart Failure: Implications for Management.

Cardiac failure review

Vitale C, Spoletini I, Rosano GM.
PMID: 30206485
Card Fail Rev. 2018 Aug;4(2):104-106. doi: 10.15420/cfr.2018.22.2.

Frailty is a complex clinical syndrome associated with ageing and chronic illness, resulting from multiple organ impairment; physiological reserves decrease and vulnerability to stressors increase. The role of frailty in cardiovascular disease has become increasingly recognised. Up to 79%...

Cite
Vitale C, Spoletini I, Rosano GM. Frailty in Heart Failure: Implications for Management. Card Fail Rev. 2018;4(2):104-106doi: 10.15420/cfr.2018.22.2.
Vitale, C., Spoletini, I., & Rosano, G. M. (2018). Frailty in Heart Failure: Implications for Management. Cardiac failure review, 4(2), 104-106. https://doi.org/10.15420/cfr.2018.22.2
Vitale, Cristiana, et al. "Frailty in Heart Failure: Implications for Management." Cardiac failure review vol. 4,2 (2018): 104-106. doi: https://doi.org/10.15420/cfr.2018.22.2
Vitale C, Spoletini I, Rosano GM. Frailty in Heart Failure: Implications for Management. Card Fail Rev. 2018 Aug;4(2):104-106. doi: 10.15420/cfr.2018.22.2. PMID: 30206485; PMCID: PMC6125710.
Copy Download .nbib Format: NLM
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy.

European heart journal

Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R, De Bonis M, Iung B, Johnson MR, Kintscher U, Kranke P, Lang IM, Morais J, Pieper PG, Presbitero P, Price S, Rosano GMC, Seeland U, Simoncini T, Swan L, Warnes CA.
PMID: 30165544
Eur Heart J. 2018 Sep 07;39(34):3165-3241. doi: 10.1093/eurheartj/ehy340.

No abstract available.

Cite
Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39(34):3165-3241doi: 10.1093/eurheartj/ehy340.
Regitz-Zagrosek, V., Roos-Hesselink, J. W., Bauersachs, J., Blomström-Lundqvist, C., Cífková, R., De Bonis, M., Iung, B., Johnson, M. R., Kintscher, U., Kranke, P., Lang, I. M., Morais, J., Pieper, P. G., Presbitero, P., Price, S., Rosano, G. M. C., Seeland, U., Simoncini, T., Swan, L., Warnes, C. A. (2018). 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. European heart journal, 39(34), 3165-3241. https://doi.org/10.1093/eurheartj/ehy340
Regitz-Zagrosek, Vera, et al. "2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy." European heart journal vol. 39,34 (2018): 3165-3241. doi: https://doi.org/10.1093/eurheartj/ehy340
Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R, De Bonis M, Iung B, Johnson MR, Kintscher U, Kranke P, Lang IM, Morais J, Pieper PG, Presbitero P, Price S, Rosano GMC, Seeland U, Simoncini T, Swan L, Warnes CA. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018 Sep 07;39(34):3165-3241. doi: 10.1093/eurheartj/ehy340. PMID: 30165544.
Copy Download .nbib Format: NLM
Disease severity and slower psychomotor speed in adults with sickle cell disease.

Blood advances

Jorgensen DR, Metti A, Butters MA, Mettenburg JM, Rosano C, Novelli EM.
PMID: 29296825
Blood Adv. 2017 Sep 14;1(21):1790-1795. doi: 10.1182/bloodadvances.2017008219. eCollection 2017 Sep 26.

Psychomotor slowing is common in children with sickle cell disease (SCD), but little is known about its severity in adults. We conducted a cross-sectional study to quantify psychomotor speed, measured with the digit symbol substitution test (DSST), in relationship...

Cite
Jorgensen DR, Metti A, Butters MA, et al. Disease severity and slower psychomotor speed in adults with sickle cell disease. Blood Adv. 2017;1(21):1790-1795doi: 10.1182/bloodadvances.2017008219.
Jorgensen, D. R., Metti, A., Butters, M. A., Mettenburg, J. M., Rosano, C., & Novelli, E. M. (2017). Disease severity and slower psychomotor speed in adults with sickle cell disease. Blood advances, 1(21), 1790-1795. https://doi.org/10.1182/bloodadvances.2017008219
Jorgensen, Dana R, et al. "Disease severity and slower psychomotor speed in adults with sickle cell disease." Blood advances vol. 1,21 (2017): 1790-1795. doi: https://doi.org/10.1182/bloodadvances.2017008219
Jorgensen DR, Metti A, Butters MA, Mettenburg JM, Rosano C, Novelli EM. Disease severity and slower psychomotor speed in adults with sickle cell disease. Blood Adv. 2017 Sep 14;1(21):1790-1795. doi: 10.1182/bloodadvances.2017008219. eCollection 2017 Sep 26. PMID: 29296825; PMCID: PMC5728099.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 194 entries